Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-3148.2009.00959.x | DOI Listing |
J Neuropsychiatry Clin Neurosci
January 2025
Editor, Journal of Neuropsychiatry and Clinical Neurosciences, and Cooper Neuropsychiatry Scholar and Professor, Department of Neurology, University of Colorado School of Medicine, Aurora.
Lancet Digit Health
January 2025
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK; Centre for Patient Reported Outcomes Research, School of Health Sciences, College of Medical and Dental Sciences, Birmingham, UK; University of Birmingham, Birmingham, UK. Electronic address:
J Vasc Access
December 2024
Voyager Biomedical, Inc., Houston, TX, USA.
Objective: We report the 6-month outcomes of the Ark Cannulation Trial (ACT) I early feasibility study. This investigation examined the Ark as a potential innovative access tool for overcoming cannulation-related challenges and improving arteriovenous fistula (AVF) dependent hemodialysis through targeted cannulation.
Methods: During this first-in-human, interventional, prospective, single arm, single site investigation, 13 patients were treated.
Am J Crit Care
November 2024
Ronald L. Hickman, Jr, is the Ruth M. Anderson Endowed Professor and Associate Dean for Research at the Frances Payne Bolton School of Nursing, Case Western Reserve University.
Background: Supporting the sleep health of surrogate decision-makers of patients in the intensive care unit is a research priority. However, few studies have approached sleep health as a multidimensional construct, instead focusing on 1 or 2 dimensions in isolation.
Objective: To holistically examine the sleep health (satisfaction, timing, efficiency, duration) of surrogate decision-makers of critically ill patients.
BMJ Open
October 2024
Department of General Practice and Family Medicine, University of Bielefeld, Bielefeld, Germany.
Introduction: Millions of persons with chronic pain across North America and Europe use opioids. While the immunosuppressive properties of opioids are associated with risks of infections, these outcomes could be mitigated through careful patient selection and monitoring practices when appropriate. It is important to recognise that some patients do benefit from a carefully tailored opioid therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!